These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 121851)

  • 1. [In vitro immunologic changes in 6 lepromatous leprosy or borderline leprosy patients treated with BCG alone or BCG and lepromin for 12 to 20 months, followed by BCG and antibiochemotherapy for 1 to 2 years].
    Saint-André P; Ferracci C; Baquillon G; Travi Piacentile M
    Acta Leprol; 1979; (76-77):311-4. PubMed ID: 121851
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eruptions in the course of immunologic reversions in lepromatous patients treated with immunomodulating agents].
    Saint-André P; Baquillon G
    Acta Leprol; 1986; 4(2):201-3. PubMed ID: 3551456
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the immunological effects of cimetidine in patients with lepromatous leprosy.
    Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does isopathic phenomenon occur in leprosy?
    Lal S; Natarajan S; Veliath AJ; Garg BR
    Lepr India; 1983 Jul; 55(3):495-9. PubMed ID: 6656207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reverse reaction during BCG therapy followed by antibiochemotherapy].
    Saint-André P; Ferracci C; Travi Piacentile M; Baquillon G
    Acta Leprol; 1979; (76-77):319-20. PubMed ID: 121853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunostimulation with BCG lepromin. Preliminary notes].
    Saint-André P; Baquillon G; Ferracci C; Ridel PR
    Acta Leprol; 1981; 85():53-5. PubMed ID: 6805235
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral BCG in desensitization of lepromin reaction].
    CAMPOS NS; ROSEMBERG J; AUN JN
    Rev Bras Tuberc Doencas Torac; 1956 Jan; 24(165):1-34. PubMed ID: 13323447
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
    Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Isopathic phenomenon' in leprosy.
    Rao BN; Satyanarayana BV; Venkatarathnam G; Reddy CR
    Dermatologica; 1975; 150(3):169-75. PubMed ID: 1158013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Result of studies of immunotherapy of lepromatous leprosy and borderline leprosy].
    Saint-André P; Baquillon G; Ferracci C; Ridel PR
    Acta Leprol; 1981; (84):39-55. PubMed ID: 6797222
    [No Abstract]   [Full Text] [Related]  

  • 14. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy.
    Rea TH; Modlin RL
    Immunol Ser; 1989; 46():723-45. PubMed ID: 2488876
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG vaccination in leprosy.
    Price JE
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.